← Back to patent-cliff list
Acetylcysteine lysinate
Tier C — Watch / tradeAcetylcysteine lysinate
Galephar Pharmaceuticals
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Not applicable
Brand：Nacystelyn
Indications (approved)：自闭症谱系障碍, Cystic fibrosis
Regional status
US
Phase III
2024-03-12
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Acetylcysteine lysinate?
Approved indications include: 自闭症谱系障碍, Cystic fibrosis.
When does the Acetylcysteine lysinate patent expire?
No public expiry year is available for Acetylcysteine lysinate yet; this page updates once verified.
How do I get a quote for Acetylcysteine lysinate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01